Dermata Therapeutics DRMA SEC Filings

NASDAQ DRMA
$1.21 -0.04 (-3.20%)
At close: Sep 9, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Dermata Therapeutics, Inc. (DRMA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index